| Literature DB >> 29421602 |
Célia Márcia Fernandes Maia1, Renato Assis Machado2, Vera Lúcia Gil-da-Silva-Lopes3, Elaine Lustosa-Mendes3, Priscila Hae Hyun Rim3, Verônica Oliveira Dias1, Daniella Reis Barbosa Martelli1, Luciano Sólia Nasser1, Ricardo D Coletta4, Hercílio Martelli-Júnior5.
Abstract
Jalili syndrome (JS) is an autosomal recessive disease characterized by a combination of cone-rode retinal dytrophy (CRD) and amelogenesis imperfect (AI). Mutations in cyclin and CBS domain divalent metal cation transport mediator 4 (CNNM4) gene cause JS. Here we described 2 families (3 members) affected by JS. In the first family, JS was caused by the homozygous p.Leu324Pro (c.971T > C) missense mutation and the affected patient developed both CRD and AI. In the second family, a specific combination of a compound heterozygous mutation was found - the p.Leu324Pro (c.971T > C) missense transition and the novel p.Tyr581* (c.1743C > G) nonsense mutation. The proband showed CRD and AI, but her father just developed eye alterations. Together, these findings suggest that the p.Leu324Pro mutation in homozygosis induces a complete phenotype with both CRD and AI, but in heterozygosis and in composition with the novel p.Tyr581* nonsense mutation in CNNM4 promotes variable clinical expressivity, particularly with lack of dental phenotypes. These different phenotypes could be explained by deletions affecting the proband's homologous allele, epistasia or interactions with environmental factors leading to residual activity of protein.Entities:
Keywords: Amelogenesis imperfecta; CNNM4; Cone-rod dystrophy; Jalili syndrome; Mutation
Mesh:
Substances:
Year: 2018 PMID: 29421602 DOI: 10.1016/j.ejmg.2018.02.003
Source DB: PubMed Journal: Eur J Med Genet ISSN: 1769-7212 Impact factor: 2.708